menogaril - CISMeF

Preferred Label : menogaril;

MeSH definition : A semisynthetic anthracycline with the amino sugar on the D ring. It displays broad-spectrum antineoplastic activity against a variety of tumors.;

MeSH synonym : 7-con-o-methylnogarol; menogarol; 7-o-methylnogarol; 7-omen;

CISMeF acronym : TUT7;

DeCS synonym : TUT7;

MeSH hyponym : menogaril, (11 beta)-Isomer; TUT-7; NSC-269148; menogaril, (5 alpha)-Isomer; menogaril, (5 alpha,11 beta)-Isomer; menogaril, (13 beta)-Isomer; tomosar; TUT 7; TUT7; NSC 269148; NSC269148;

MeSH CAS label : 2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-9,16-dione, 4-(dimethylamino)-3,4,5,6,11,12,13,14-octahydro-3,5,8,10,13-pentahydroxy-11-methoxy-6,13-dimethyl-, (2R-(2alpha,3beta,4alpha,5beta,6alpha,11alpha,13alpha))-;

MeSH Related Number : menogaril, (11 beta)-Isomer; menogaril, (5 alpha)-Isomer; menogaril, (5 alpha,11 beta)-Isomer; menogaril, (13 beta)-Isomer; 105119-19-5 ((5 alpha,11 beta)-isomer); 111688-19-8 ((5 alpha)-isomer); 114926-58-8 ((13 beta)-isomer); 64267-47-6 ((11 beta)-isomer); 71628-96-1 (Menogaril);

Registry Number MeSH : 71628-96-1;

Related CAS MeSH : 64267-47-6 (Menogaril, (11 beta)-Isomer); 111688-19-8 (Menogaril, (5 alpha)-Isomer); 105119-19-5 (Menogaril, (5 alpha,11 beta)-Isomer); 114926-58-8 (Menogaril, (13 beta)-Isomer);

Is substance : O;

UNII : 8JSV4O30HQ;

InChIKey : LWYJUZBXGAFFLP-AOZXJLOUSA-N;

Details

Origin ID

D017290;

UMLS CUI

C0127527;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Menogaril [NCIt concept]
Pharmacological action(s)
- antibiotics, antineoplastic [MeSH Descriptor]
Record concept(s)
- NSC-269148 [MeSH concept]
- TUT-7 [MeSH concept]
- menogaril [MeSH concept]
- menogaril, (11 beta)-Isomer [MeSH concept]
- menogaril, (13 beta)-Isomer [MeSH concept]
- menogaril, (5 alpha)-Isomer [MeSH concept]
- menogaril, (5 alpha,11 beta)-Isomer [MeSH concept]
- tomosar [MeSH concept]
Related MeSH Supplementary Concept(s)
- 7-deoxynogarol [MeSH Supplementary Concept]
- N-demethylmenogaril [MeSH Supplementary Concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Menogaril [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients